HLA DRB1 alleles in association with acute and chronic myeloid leukemia and evaluation of their role as markers for selection of the line of treatment
Last updated: 05 Jan 2025
10.21608/ejmm.2022.247182
AML, CML, HLA-DRB1 typing
Mona
Morsi
Medical Microbiology and Immunology Department, Faculty of Medicine, University of Alexandria, Egypt
morsirg@gmail.com
Alexandria
Maha
Elgharbawy
Medical microbiology and immunology department, Faculty of medicine, Alexandria university
maha.elgharbawy@gmail.com
Nahla
Hamed
Hematology department, faculty of medicine, Alexandria university, Egypt
nahla.hamed@alexmed.edu.eg
Haidy
Mamdouh
Medical microbiology and immunology department, Faculty of medicine, Alexandria university
dodzi_128@hotmail.com
Shams
Arafa
Abd elfattah
Medical microbiology and immunology, faculty of medicine, Alexandria university
shams.arafa@alexmed.edu.eg
Alexandria
0000-0002-9683-4530
31
3
35368
2022-07-01
2022-07-01
2022-07-01
37
42
1110-2179
2537-0979
https://ejmm.journals.ekb.eg/article_247182.html
https://ejmm.journals.ekb.eg/service?article_code=247182
247,182
New and original researches in the field of Microbiology.
2,038
Journal
Egyptian Journal of Medical Microbiology
https://ejmm.journals.ekb.eg/
HLA DRB1 alleles in association with acute and chronic myeloid leukemia and evaluation of their role as markers for selection of the line of treatment
Details
Type
Article
Created At
23 Jan 2023